Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Penka

Showing results (51-60 of 105) with videos related to

Pageof 11
Sort By:
Neoplasma|September 5, 2009
Phenotype of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significanceL Kovarova, I Buresova, T Buchler, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|September 15, 2017
Biobanking - the First Step to Successful Liquid Biopsy ExperimentsM Almasi, S Sevcikova, M Penka, et al.
Medical Oncology (Northwood, London, England)|October 5, 2006
Isolation and expansion of allogeneic myeloma-specific interferon-gamma producing T cells for adoptive immunotherapyDarina Ocadlikova, L Zahradova, L Kovarova, et al.
International Journal of Obstetric Anesthesia|September 13, 2011
Severe postpartum haemorrhage treated with recombinant activated factor VII in 80 Czech patients: analysis of the UniSeven registryJ Blatný, D Seidlová, M Penka, et al.
Vnitrni Lekarstvi|April 28, 2006
[The preparation of a patient with long-term anticoagulant cumarin treatment for invasive surgery]M Penka, A Buliková, J Gumulec, et al.
International Journal of Hematology|August 10, 2010
Optimization of immunomagnetic selection of myeloma cells from bone marrow using magnetic activated cell sortingJana Cumova, L Kovarova, A Potacova, et al.
Vnitrni Lekarstvi|July 2, 2013
[The effectiveness of anagrelide treatment in patients with Ph negative myeloproliferative diseases: influence on the incidence of thrombosis in the data from the Registry of patients with essential thrombocythemia and thrombocythemia associated with other myeloproliferative diseases treated with Thromboreductin® to the end of 2012]M Penka, J Schwarz, P Ovesná, et al.
Ceska Gynekologie|October 8, 2010
[Recombinant activated factor VII in the treatment of life threatening post-partum haemorrhage; registry UniSeven in the Czech Republic]Dagmar Seidlová, J Blatný, M Penka, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|September 15, 2017
Minimal Residual Disease Assessment in Multiple Myeloma by Multiparametric Flow CytometryL Rihova, P Vsianska, R Bezdekova, et al.
Vnitrni Lekarstvi|October 1, 1994
[Late and slow diagnosis of acute promyelocytic leukemias--the main cause of early death]P Lemez, J Schwarz, J Jelínek, et al.
Pageof 11

Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
Neoplasma|September 5, 2009
Phenotype of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significanceL Kovarova, I Buresova, T Buchler, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|September 15, 2017
Biobanking - the First Step to Successful Liquid Biopsy ExperimentsM Almasi, S Sevcikova, M Penka, et al.
Medical Oncology (Northwood, London, England)|October 5, 2006
Isolation and expansion of allogeneic myeloma-specific interferon-gamma producing T cells for adoptive immunotherapyDarina Ocadlikova, L Zahradova, L Kovarova, et al.
International Journal of Obstetric Anesthesia|September 13, 2011
Severe postpartum haemorrhage treated with recombinant activated factor VII in 80 Czech patients: analysis of the UniSeven registryJ Blatný, D Seidlová, M Penka, et al.
Vnitrni Lekarstvi|April 28, 2006
[The preparation of a patient with long-term anticoagulant cumarin treatment for invasive surgery]M Penka, A Buliková, J Gumulec, et al.
International Journal of Hematology|August 10, 2010
Optimization of immunomagnetic selection of myeloma cells from bone marrow using magnetic activated cell sortingJana Cumova, L Kovarova, A Potacova, et al.
Vnitrni Lekarstvi|July 2, 2013
[The effectiveness of anagrelide treatment in patients with Ph negative myeloproliferative diseases: influence on the incidence of thrombosis in the data from the Registry of patients with essential thrombocythemia and thrombocythemia associated with other myeloproliferative diseases treated with Thromboreductin® to the end of 2012]M Penka, J Schwarz, P Ovesná, et al.
Ceska Gynekologie|October 8, 2010
[Recombinant activated factor VII in the treatment of life threatening post-partum haemorrhage; registry UniSeven in the Czech Republic]Dagmar Seidlová, J Blatný, M Penka, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|September 15, 2017
Minimal Residual Disease Assessment in Multiple Myeloma by Multiparametric Flow CytometryL Rihova, P Vsianska, R Bezdekova, et al.
Vnitrni Lekarstvi|October 1, 1994
[Late and slow diagnosis of acute promyelocytic leukemias--the main cause of early death]P Lemez, J Schwarz, J Jelínek, et al.
Pageof 11